nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBA4A—amyotrophic lateral sclerosis	0.926	1	CbGaD
Podofilox—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—RNF19A—amyotrophic lateral sclerosis	0.00431	0.0729	CbGpPWpGaD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—RNF19A—amyotrophic lateral sclerosis	0.00367	0.062	CbGpPWpGaD
Podofilox—TUBA4A—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00301	0.051	CbGpPWpGaD
Podofilox—TUBA4A—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00275	0.0465	CbGpPWpGaD
Podofilox—Etoposide—GSTP1—amyotrophic lateral sclerosis	0.00237	0.76	CrCbGaD
Podofilox—TUBA4A—hindbrain—amyotrophic lateral sclerosis	0.00191	0.158	CbGeAlD
Podofilox—TUBB—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00134	0.0227	CbGpPWpGaD
Podofilox—TUBB—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00124	0.0209	CbGpPWpGaD
Podofilox—TUBA4A—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00124	0.0209	CbGpPWpGaD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00118	0.02	CbGpPWpGaD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00111	0.0187	CbGpPWpGaD
Podofilox—TUBB—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00109	0.0185	CbGpPWpGaD
Podofilox—TUBA4A—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00109	0.0185	CbGpPWpGaD
Podofilox—TUBA4A—brainstem—amyotrophic lateral sclerosis	0.00109	0.0904	CbGeAlD
Podofilox—TUBA4A—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.00105	0.0178	CbGpPWpGaD
Podofilox—TUBB—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00105	0.0178	CbGpPWpGaD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.001	0.017	CbGpPWpGaD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.001	0.017	CbGpPWpGaD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.001	0.017	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.001	0.017	CbGpPWpGaD
Podofilox—TUBB—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00093	0.0157	CbGpPWpGaD
Podofilox—TUBA4A—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.000887	0.015	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.000875	0.0148	CbGpPWpGaD
Podofilox—NR3C1—nerve—amyotrophic lateral sclerosis	0.000865	0.0715	CbGeAlD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.000854	0.0144	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.000836	0.0141	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.000773	0.0131	CbGpPWpGaD
Podofilox—TUBA4A—medulla oblongata—amyotrophic lateral sclerosis	0.000762	0.063	CbGeAlD
Podofilox—TUBB—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.000754	0.0128	CbGpPWpGaD
Podofilox—TUBB—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.000754	0.0128	CbGpPWpGaD
Podofilox—TUBA4A—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.000754	0.0128	CbGpPWpGaD
Podofilox—Etoposide—PTGS2—amyotrophic lateral sclerosis	0.000751	0.24	CrCbGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.000744	0.0126	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.000744	0.0126	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.000744	0.0126	CbGpPWpGaD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—amyotrophic lateral sclerosis	0.000686	0.0116	CbGpPWpGaD
Podofilox—TUBA4A—spinal cord—amyotrophic lateral sclerosis	0.00068	0.0562	CbGeAlD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.000668	0.0113	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000648	0.011	CbGpPWpGaD
Podofilox—NR3C1—hindbrain—amyotrophic lateral sclerosis	0.000648	0.0535	CbGeAlD
Podofilox—TUBB—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.000641	0.0108	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.000632	0.0107	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.000611	0.0103	CbGpPWpGaD
Podofilox—TUBA4A—nervous system—amyotrophic lateral sclerosis	0.000573	0.0473	CbGeAlD
Podofilox—TUBB—medulla oblongata—amyotrophic lateral sclerosis	0.000559	0.0462	CbGeAlD
Podofilox—TUBA4A—central nervous system—amyotrophic lateral sclerosis	0.000552	0.0456	CbGeAlD
Podofilox—TUBA4A—cerebellum—amyotrophic lateral sclerosis	0.000539	0.0445	CbGeAlD
Podofilox—TUBA4A—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000528	0.00893	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000509	0.00861	CbGpPWpGaD
Podofilox—TUBB—spinal cord—amyotrophic lateral sclerosis	0.000498	0.0412	CbGeAlD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000485	0.0082	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000467	0.0079	CbGpPWpGaD
Podofilox—TUBA4A—brain—amyotrophic lateral sclerosis	0.000438	0.0362	CbGeAlD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000425	0.00719	CbGpPWpGaD
Podofilox—NR3C1—embryo—amyotrophic lateral sclerosis	0.000405	0.0335	CbGeAlD
Podofilox—TUBA4A—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.0004	0.00677	CbGpPWpGaD
Podofilox—TUBB—cerebellum—amyotrophic lateral sclerosis	0.000395	0.0327	CbGeAlD
Podofilox—TUBA4A—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000386	0.00652	CbGpPWpGaD
Podofilox—NR3C1—brainstem—amyotrophic lateral sclerosis	0.000371	0.0307	CbGeAlD
Podofilox—TUBA4A—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000366	0.00619	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000347	0.00586	CbGpPWpGaD
Podofilox—TUBB—brain—amyotrophic lateral sclerosis	0.000321	0.0265	CbGeAlD
Podofilox—TUBA4A—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.00031	0.00525	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000306	0.00518	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000303	0.00513	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000296	0.005	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000289	0.00489	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000282	0.00477	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00028	0.00473	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000265	0.00448	CbGpPWpGaD
Podofilox—NR3C1—medulla oblongata—amyotrophic lateral sclerosis	0.000259	0.0214	CbGeAlD
Podofilox—TUBA4A—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000252	0.00427	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00025	0.00423	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000249	0.0042	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000241	0.00407	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00024	0.00406	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00024	0.00406	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.00024	0.00406	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000238	0.00403	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000231	0.00391	CbGpPWpGaD
Podofilox—NR3C1—spinal cord—amyotrophic lateral sclerosis	0.000231	0.0191	CbGeAlD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000226	0.00382	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000222	0.00375	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000218	0.00368	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000215	0.00363	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000215	0.00363	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000215	0.00363	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000204	0.00345	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000203	0.00343	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000203	0.00342	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000201	0.0034	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000197	0.00334	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000197	0.00334	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000197	0.00334	CbGpPWpGaD
Podofilox—NR3C1—nervous system—amyotrophic lateral sclerosis	0.000195	0.0161	CbGeAlD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—amyotrophic lateral sclerosis	0.000194	0.00329	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000193	0.00327	CbGpPWpGaD
Podofilox—NR3C1—central nervous system—amyotrophic lateral sclerosis	0.000187	0.0155	CbGeAlD
Podofilox—NR3C1—cerebellum—amyotrophic lateral sclerosis	0.000183	0.0151	CbGeAlD
Podofilox—TUBB—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000182	0.00308	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000179	0.00302	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00017	0.00287	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000168	0.00284	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000168	0.00284	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000168	0.00284	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.00015	0.00254	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.00015	0.00254	CbGpPWpGaD
Podofilox—NR3C1—brain—amyotrophic lateral sclerosis	0.000149	0.0123	CbGeAlD
Podofilox—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000147	0.0122	CbGeAlD
Podofilox—TOP2A—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000143	0.00241	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000142	0.0024	CbGpPWpGaD
Podofilox—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000142	0.0117	CbGeAlD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000138	0.00233	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.00229	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000133	0.00226	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000132	0.00223	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000128	0.00216	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000128	0.00216	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000121	0.00204	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000116	0.00197	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000109	0.00184	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000106	0.00178	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.00177	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000102	0.00173	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	9.67e-05	0.00164	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.3e-05	0.00157	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.2e-05	0.00156	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	9.16e-05	0.00155	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	8.99e-05	0.00152	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	8.52e-05	0.00144	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.5e-05	0.00144	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.9e-05	0.00134	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IGF1—amyotrophic lateral sclerosis	7.67e-05	0.0013	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	7.63e-05	0.00129	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.52e-05	0.00127	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.43e-05	0.00126	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.26e-05	0.00123	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.1e-05	0.0012	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	7.08e-05	0.0012	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	6.71e-05	0.00113	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—FUS—amyotrophic lateral sclerosis	6.23e-05	0.00105	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	6.21e-05	0.00105	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	6.04e-05	0.00102	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.01e-05	0.00102	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	5.58e-05	0.000944	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	5.47e-05	0.000926	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.4e-05	0.000914	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.33e-05	0.000901	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	5.1e-05	0.000863	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.09e-05	0.000861	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RARA—amyotrophic lateral sclerosis	5.08e-05	0.000859	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.64e-05	0.000784	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.54e-05	0.000768	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	4.36e-05	0.000737	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.33e-05	0.000732	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	4.14e-05	0.0007	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	4.14e-05	0.0007	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.86e-05	0.000653	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	3.79e-05	0.00064	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.52e-05	0.000595	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—amyotrophic lateral sclerosis	3.5e-05	0.000592	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	3.31e-05	0.00056	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—amyotrophic lateral sclerosis	3.31e-05	0.000559	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.25e-05	0.000549	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.2e-05	0.000542	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.99e-05	0.000506	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—amyotrophic lateral sclerosis	2.81e-05	0.000475	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.49e-05	0.000421	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.49e-05	0.000421	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.28e-05	0.000385	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.27e-05	0.000384	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.12e-05	0.000358	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.09e-05	0.000354	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.99e-05	0.000337	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—amyotrophic lateral sclerosis	1.97e-05	0.000332	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.91e-05	0.000322	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.8e-05	0.000304	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.72e-05	0.000291	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.57e-05	0.000265	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.36e-05	0.000231	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.26e-05	0.000213	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.07e-05	0.000182	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.03e-05	0.000175	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.24e-06	0.000156	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.49e-06	0.000144	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	6.99e-06	0.000118	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.56e-06	9.4e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.11e-06	8.63e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.79e-06	8.09e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	4.2e-06	7.1e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.88e-06	4.87e-05	CbGpPWpGaD
